Abstract
Aim: For assessment of concentrations of biopharmaceuticals, for example, therapeutic drug monitoring, dried blood sampling of capillary blood is a convenient alternative to traditional venepuncture sampling. We investigated an alternative to dried blood spot collection on filter paper: sampling capillary blood using the Mitra® microsampler. Materials and Methods: Therapeutic monoclonal antibodies were spiked in whole blood, sampled using filter paper and Mitra microsampler and concentrations measured using specific ELISAs. Results: Good recoveries of adalimumab, infliximab, ustekinumab, vedolizumab, tocilizumab, natalizumab and rituximab were found up to 1 month of storage at room temperature, averaging 95.2% for the Mitra microsampler and 92.9% for Whatman® paper. Both hemoglobin and potassium yield satisfactory estimates for the volume of the cellular fraction of blood samples in combination with the Mitra microsampler. Conclusion: We established practical protocols for the estimation of serum/plasma concentrations of therapeutic antibodies via capillary blood microsampling.
Papers of special note have been highlighted as: • of interest
References
- 1 Developing a therapeutic range of adalimumab serum concentrations in management of psoriasis: a step toward personalized treatment. JAMA Dermatol. 151(6), 616–622 (2015).
- 2 Key findings towards optimising adalimumab treatment: the concentration–effect curve. Ann. Rheum. Dis. 74(3), 513–518 (2015).
- 3 Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease. Gastroenterology 148(7), 1320e1323–1329e1323 (2015).
- 4 Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial. Ann. Rheum. Dis. 77(4), 484–487 (2017).
- 5 Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti-adalimumab in patients with inflammatory diseases. Br. J Clin. Pharmacol. 83, 2474–2484 (2017). • Describes comparison between dried blood spot and venepuncture for adalimumab.
- 6 . Therapeutic drug monitoring by dried blood spot: progress to date and future directions. Clin. Pharmacokinet. 53(11), 961–973 (2014).
- 7 . Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis. Anal. Chem. 86(16), 8489–8495 (2014). • Describes Mitra® microsampler.
- 8 Functional analysis of the anti-adalimumab response using patient-derived monoclonal antibodies. J. Biol. Chem. 289, 34482–34488 (2014).
- 9 . Prediction of the hematocrit of dried blood spots via potassium measurement on a routine clinical chemistry analyzer. Anal. Chem. 85(1), 404–410 (2013).
- 10 . Specific gravity of blood and plasma at 4 and 37 degrees C. Clin. Chem. 20(5), 615–616 (1974).
- 11 The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab-treated patients with psoriasis in a clinical-practice setting. Br. J. Dermatol. 173(3), 855–857 (2015).
- 12 Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study. Scand. J. Rheumatol. 46(2), 87–94 (2017).
- 13 Measurement of serum levels of natalizumab, an immunoglobulin G4 therapeutic monoclonal antibody. Anal. Biochem. 411(2), 271–276 (2011).
- 14 Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis. Ann. Rheum. Dis. 69(2), 409–412 (2010).
- 15 Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays. Aliment. Pharmacol. Ther. 36(8), 765–771 (2012).
- 16 A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit. Bioanalysis 7(6), 653–659 (2015).
- 17 . Drug monitoring by volumetric absorptive microsampling: method development considerations to mitigate hematocrit effects. Bioanalysis 10(4), 241–255 (2018).
